CNSX:VP Vodis Pharmaceuticals (VP) Stock Price, News & Analysis → Collect 10%+ Dividends from AI's Explosive Growth? (From The Oxford Club) (Ad) Free VP Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume51,582 shsAverage Volume1,714 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vodis Pharmaceuticals alerts: Email Address Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… About Vodis Pharmaceuticals Stock (CNSX:VP)Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.Read More Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… VP Stock News HeadlinesMay 7, 2024 | tmcnet.comScorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonaldMay 6, 2024 | reuters.comVP Harris announces more than $100 mln to support auto workersMarch 27, 2024 | tmcnet.comCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™March 22, 2024 | msn.comStates' drug pricing boards off to a slow startFebruary 25, 2024 | msn.comVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference CallFebruary 7, 2024 | markets.businessinsider.comAbivax appoints Ana Sharma as Vice President, Global Head of QualityJanuary 24, 2024 | markets.businessinsider.comMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s HealthDecember 14, 2023 | msn.comDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023December 7, 2023 | msn.comBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsDecember 7, 2023 | abcnews.go.comThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsDecember 1, 2023 | msn.comAmneal Pharma in pact with Strides to launch generic VascepaNovember 6, 2023 | markets.businessinsider.comAnavex Life Sciences Appoints Senior VP of Regulatory AffairsOctober 14, 2023 | foxnews.comXpeng's vice president suspended amid corruption investigation in supply chain managementOctober 9, 2023 | marketwatch.comLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart DrugOctober 4, 2023 | markets.businessinsider.comStrengthening of vertical integration: Exyte completes acquisition of pure media specialist IntegaSeptember 19, 2023 | newsweek.comVice PresidentAugust 28, 2023 | usatoday.comRepublican voters want Donald Trump. And his vice president? How about more Trump?August 22, 2023 | news.yahoo.comTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesAugust 1, 2023 | msn.comVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call TranscriptMay 29, 2023 | news.yahoo.comWhat has Kamala Harris done as vice president?March 31, 2023 | nytimes.comVice President Kamala Harris: Latest NewsFebruary 1, 2023 | yahoo.comIonis announces GSK has advanced bepirovirsen into Phase 3 developmentJanuary 27, 2023 | yahoo.comZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)January 12, 2023 | marketwatch.comThe way Medicare will negotiate down prescription drug prices takes shapeJanuary 10, 2023 | msn.comGlenmark Pharmaceuticals launches congestive heart failure injection in United StatesSee More Headlines Receive VP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vodis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCNSX:VP CUSIPN/A CIKN/A Webvodis.ca Phone778-990-8985FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Brian R. Gusko (Age 52)Advisor Mr. Mark Lotz B.B.A.C.A., CPA, Interim CEO, CFO & DirectorKey Competitors45525 (CUR.TO)TSE:CURCanada House Wellness GroupCNSX:CHVDirexion Daily Healthcare Bull 3X SharesCNSX:CUREMatica EnterprisesCNSX:MMJPreveCeutical MedicalCNSX:PREVView All Competitors VP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Vodis Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vodis Pharmaceuticals investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). How do I buy shares of Vodis Pharmaceuticals? Shares of VP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:VP) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vodis Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vodis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.